Retinitis Pigmentosa (RP) Completed Phase 2 Trials for Valproic acid (DB00313)

Also known as: Retinitis Pigmentosa / Pigmentary maculopathy / Albipunctate retinal dystrophy

IndicationStatusPhase
DBCOND0056216 (Retinitis Pigmentosa (RP))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01233609Trial of Oral Valproic Acid for Retinitis PigmentosaTreatment
NCT01399515Efficacy and Safety of Oral Valproic Acid for Retinitis PigmentosaTreatment